BACKGROUND: The aim of this study was to provide insight into the relationship between information provision and illness perceptions among cancer survivors. METHODS: All individuals diagnosed with lymphoma, multiple myeloma, endometrial or colorectal cancer between 1998 and 2008, as registered in the Eindhoven Cancer Registry, were eligible for participation. In total, 4446 survivors received a questionnaire including the EORTC-QLQ-INFO25 and the Brief Illness Perception Questionnaire; 69% responded (n = 3080). RESULTS: Lymphoma and multiple myeloma patients were most satisfied with the information they received, and they perceived to having received more information about their treatment and other services (after care) compared with colorectal and endometrial cancer survivors (p < 0.05). Multiple myeloma patients reported the highest scores (conceptualized their illness as very serious) on the illness perception scales. The perceived receipt of more disease-specific information was associated with more personal and treatment control and a better understanding of the illness, whereas the perceived receipt of more information about other services was associated with more negative consequences of the illness on the patients' life, longer perceived duration of illness, less treatment control, more symptoms attributable to the illness, less understanding of, and stronger emotional reaction to the illness (p < 0.05). Satisfaction with the received information was associated with better illness perception on all subscales, except for personal control (p < 0.05). CONCLUSION: Improving the patients' illness perceptions by tailoring the information provision to the needs of patients may help patients to get a more coherent understanding of their illness and will possibly lead to a better health-related quality of life.
BACKGROUND: The aim of this study was to provide insight into the relationship between information provision and illness perceptions among cancer survivors. METHODS: All individuals diagnosed with lymphoma, multiple myeloma, endometrial or colorectal cancer between 1998 and 2008, as registered in the Eindhoven Cancer Registry, were eligible for participation. In total, 4446 survivors received a questionnaire including the EORTC-QLQ-INFO25 and the Brief Illness Perception Questionnaire; 69% responded (n = 3080). RESULTS:Lymphoma and multiple myelomapatients were most satisfied with the information they received, and they perceived to having received more information about their treatment and other services (after care) compared with colorectal and endometrial cancer survivors (p < 0.05). Multiple myelomapatients reported the highest scores (conceptualized their illness as very serious) on the illness perception scales. The perceived receipt of more disease-specific information was associated with more personal and treatment control and a better understanding of the illness, whereas the perceived receipt of more information about other services was associated with more negative consequences of the illness on the patients' life, longer perceived duration of illness, less treatment control, more symptoms attributable to the illness, less understanding of, and stronger emotional reaction to the illness (p < 0.05). Satisfaction with the received information was associated with better illness perception on all subscales, except for personal control (p < 0.05). CONCLUSION: Improving the patients' illness perceptions by tailoring the information provision to the needs of patients may help patients to get a more coherent understanding of their illness and will possibly lead to a better health-related quality of life.
Authors: Na Zhang; Richard Fielding; Inda Soong; Karen K K Chan; Janice Tsang; Victor Lee; Conrad Lee; Alice Ng; Wing Kin Sze; Pamela Tin; Wendy Wing Tak Lam Journal: Support Care Cancer Date: 2015-08-28 Impact factor: 3.603
Authors: Melissa S Y Thong; Floortje Mols; Adrian A Kaptein; Dorry Boll; Caroline Vos; Johanna M A Pijnenborg; Lonneke V van de Poll-Franse; Nicole P M Ezendam Journal: Support Care Cancer Date: 2018-09-13 Impact factor: 3.603
Authors: Masoumeh Pourfallahi; Mohammad Gholami; Mohammad Javad Tarrahi; Tahereh Toulabi; Parastou Kordestani Moghadam Journal: Support Care Cancer Date: 2019-05-07 Impact factor: 3.603
Authors: Konstantinos Kotsis; Paraskevi V Voulgari; Niki Tsifetaki; Alexandros A Drosos; André F Carvalho; Thomas Hyphantis Journal: Rheumatol Int Date: 2014-04-27 Impact factor: 2.631
Authors: Nicola M Gray; Susan J Hall; Susan Browne; Marie Johnston; Amanda J Lee; Una Macleod; Elizabeth D Mitchell; Leslie Samuel; Neil C Campbell Journal: Support Care Cancer Date: 2014-02 Impact factor: 3.603
Authors: Mary Playdon; Leah M Ferrucci; Ruth McCorkle; Kevin D Stein; Rachel Cannady; Tara Sanft; Brenda Cartmel Journal: J Cancer Surviv Date: 2016-01-07 Impact factor: 4.442
Authors: Aulia Iskandarsyah; Cora de Klerk; Dradjat R Suardi; Monty P Soemitro; Sawitri S Sadarjoen; Jan Passchier Journal: Support Care Cancer Date: 2013-06-18 Impact factor: 3.603
Authors: L Cohen; J Hamer; C Helwig; K Fergus; A Kiss; R Mandel; B Dawson; A Landsberg; K Shein; N Kay; E Warner Journal: Curr Oncol Date: 2016-04-13 Impact factor: 3.677